A

AEON Biopharma
D

AEON

0.12110
USD
-0.01
(-7.77%)
مغلق
حجم التداول
177,032
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
9,684,451
المقالات

العنوان: AEON Biopharma

القطاع: Healthcare
الصناعة: Biotechnology
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.